跳至主要内容
临床试验/ACTRN12610000199011
ACTRN12610000199011尚未招募4 期

In glaucoma or ocular hypertension, have the two presentations of bimatoprost 0.03% availabe in Brazil similar safety and efficacy profile?

Ophthalmology Department of the State University of Campinas0 个研究点目标入组 54 人开始时间: 2010年3月9日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Ocular Hypertension:
  • - intraocular pressure higher than 21mmHg with no medication
  • -normal visual field test
  • -normal optic nerve appearance
  • -intraocular pressure higher than 21mmHg with no medication
  • -glaucomatous visual filed test
  • -glacuomatous optic nerve appearance

排除标准

  • - visual acuity worse than 20/40 (Snellen scale)
  • - intraocular pressure higher than 36mmHg with medication
  • - diabetes
  • -intraocular laser or surgery on the last 6 months
  • -ocular trauma on the last 6 months

研究者

发起方
Ophthalmology Department of the State University of Campinas

相似试验